300142 沃森生物
交易中 09-29 13:34:54
资讯
新帖
简况
沃森生物：公司向特定对象发行股票申请文件已获得深交所受理
证券之星 · 09-18
沃森生物：公司向特定对象发行股票申请文件已获得深交所受理
沃森生物：新型冠状病毒mRNA疫苗获药品注册证书
证券之星 · 09-18
沃森生物：新型冠状病毒mRNA疫苗获药品注册证书
沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段
证券之星 · 09-15
沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段
沃森生物：子公司新冠mRNA疫苗获批上市
格隆汇 · 09-10
沃森生物：子公司新冠mRNA疫苗获批上市
公司问答丨沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段
格隆汇 · 09-08
公司问答丨沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段
沃森生物：本次向特定对象发行股票尚需通过深交所审核
证券之星 · 09-08
沃森生物：本次向特定对象发行股票尚需通过深交所审核
沃森生物：本次收购完成后，公司持有玉溪沃森的股权比例进一步提升
证券之星 · 09-04
沃森生物：本次收购完成后，公司持有玉溪沃森的股权比例进一步提升
沃森生物：新型冠状病毒变异株mRNA疫苗正推进上市许可
证券之星 · 08-31
沃森生物：新型冠状病毒变异株mRNA疫苗正推进上市许可
沃森生物（300142）披露2026年半年度报告，8月31日股价下跌4.83%
证券之星 · 08-31
沃森生物（300142）披露2026年半年度报告，8月31日股价下跌4.83%
沃森生物：已建立mRNA疫苗研发到商业化生产的完整能力
证券之星 · 08-31
沃森生物：已建立mRNA疫苗研发到商业化生产的完整能力
沃森生物(300142)6月30日股东户数13.1万户，较上期增加10.56%
证券之星 · 08-29
沃森生物(300142)6月30日股东户数13.1万户，较上期增加10.56%
图解沃森生物中报：第二季度单季净利润同比下降239.42%
证券之星 · 08-29
图解沃森生物中报：第二季度单季净利润同比下降239.42%
沃森生物最新公告：定增申请获深交所受理
证券之星 · 08-27
沃森生物最新公告：定增申请获深交所受理
沃森生物：2026年度向特定对象发行股票获深交所受理
格隆汇 · 08-27
沃森生物：2026年度向特定对象发行股票获深交所受理
8月26日沃森生物涨5.83%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 08-26
8月26日沃森生物涨5.83%，招商国证生物医药指数(LOF)C基金重仓该股
8月24日沃森生物跌7.45%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 08-24
8月24日沃森生物跌7.45%，招商国证生物医药指数(LOF)C基金重仓该股
8月21日沃森生物涨6.48%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 08-21
8月21日沃森生物涨6.48%，招商国证生物医药指数(LOF)C基金重仓该股
8月20日沃森生物创60日新高，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 08-20
8月20日沃森生物创60日新高，招商国证生物医药指数(LOF)C基金重仓该股
生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报
格隆汇 · 08-20
生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报
四大指数集体高开！生物医药板块大爆发，康希诺、沃森生物一字20CM涨停，农业、煤炭板块下跌｜开盘播报
每日经济新闻 · 08-20
四大指数集体高开！生物医药板块大爆发，康希诺、沃森生物一字20CM涨停，农业、煤炭板块下跌｜开盘播报
加载更多
公司概况
公司名称：
云南沃森生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2010-11-12
主营业务：
云南沃森生物技术股份有限公司的主营业务是人用疫苗等生物技术药的研发、生产和销售。公司的主要产品是疫苗产品。
发行价格：
95.00
{"stockData":{"symbol":"300142","market":"SZ","secType":"STK","nameCN":"沃森生物","latestPrice":13.44,"timestamp":1790660094000,"preClose":13.6,"halted":0,"volume":55744498,"delay":0,"changeRate":-0.0118,"floatShares":1578000000,"shares":1599000000,"eps":0.1181,"marketStatus":"交易中","change":-0.16,"latestTime":"09-29 13:34:54","open":13.51,"high":13.88,"low":13.37,"amount":757000000,"amplitude":0.0375,"askPrice":13.45,"askSize":684,"bidPrice":13.44,"bidSize":55,"shortable":0,"etf":0,"ttmEps":0.1181,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1790665200000},"marketStatusCode":2,"adr":0,"adjPreClose":13.6,"symbolType":"stock","openAndCloseTimeList":[[1790645400000,1790652600000],[1790658000000,1790665200000]],"highLimit":14.96,"lowLimit":12.24,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1599348541,"isCdr":false,"pbRate":3.12,"roa":"--","peRate":113.801863,"roe":"0.74%","epsLYR":0.1111,"committee":0.659791,"marketValue":21495000000,"turnoverRate":0.0353,"status":1,"floatMarketCap":21206000000},"requestUrl":"/m/hq/s/300142","defaultTab":"news","newsList":[{"id":"2668292925","title":"沃森生物：公司向特定对象发行股票申请文件已获得深交所受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2668292925","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668292925?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:48","pubTimestamp":1789735698,"startTime":"0","endTime":"0","summary":"公司于2026年8月27日收到深圳证券交易所出具的《关于受理云南沃森生物技术股份有限公司向特定对象发行股票申请文件的通知》，本次发行项目的申请文件已获得深交所受理。鉴于本次发行事项尚在持续推进中，本次向特定对象发行股票事项最终能否通过深交所审核，并获得中国证监会同意注册的批复及其时间尚存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800034929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0046","BK0070","BK0239","300142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668460719","title":"沃森生物：新型冠状病毒mRNA疫苗获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2668460719","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668460719?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:21","pubTimestamp":1789719668,"startTime":"0","endTime":"0","summary":"公司基于mRNA平台技术策略迭代开发的新型冠状病毒mRNA疫苗已于2026年9月10日收到《药品注册证书》。另有呼吸道合胞病毒mRNA疫苗、冻干带状疱疹病毒mRNA疫苗已获得《药物临床试验批准通知书》，正在开展I期临床试验准备相关工作。关于公司mRNA技术平台及具体产品的研发进展，请您查阅公司在巨潮资讯网披露的定期报告及相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800024134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0046","BK0070","BK0239","300142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667941766","title":"沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2667941766","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667941766?lang=zh_cn&edition=full","pubTime":"2026-09-15 08:27","pubTimestamp":1789432024,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物(300142)09月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司九价hpv疫苗数据整理要多久才能整理好提交审批沃森生物回复：尊敬的投资者，您好！感谢您对公司的关注。公司九价HPV疫苗目前处于III期临床研究阶段，公司将按照国家对于疫苗注册临床试验的有关程序和要求推进在研疫苗产品的相关工作，有关信息请持续关注公司后续披露的公告和定期报告。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500006267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142","BK0077","BK0239","BK0046","BK0070","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659892","title":"沃森生物：子公司新冠mRNA疫苗获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659892","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666659892?lang=zh_cn&edition=full","pubTime":"2026-09-10 19:50","pubTimestamp":1789041059,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0046","300142","BK0077","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665752328","title":"公司问答丨沃森生物：公司九价HPV疫苗目前处于III期临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2665752328","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665752328?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:41","pubTimestamp":1788853315,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300142","BK0239","159646","BK0070","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344548","title":"沃森生物：本次向特定对象发行股票尚需通过深交所审核","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344548","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665344548?lang=zh_cn&edition=full","pubTime":"2026-09-08 11:33","pubTimestamp":1788838396,"startTime":"0","endTime":"0","summary":"2026年8月27日，公司收到深圳证券交易所出具的《关于受理云南沃森生物技术股份有限公司向特定对象发行股票申请文件的通知》，本次发行项目的申请文件已获得深交所受理。公司本次向特定对象发行股票尚需通过深交所审核，并获得中国证监会同意注册的批复后方可实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800015110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300142","BK0046","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664387386","title":"沃森生物：本次收购完成后，公司持有玉溪沃森的股权比例进一步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2664387386","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664387386?lang=zh_cn&edition=full","pubTime":"2026-09-04 11:37","pubTimestamp":1788493056,"startTime":"0","endTime":"0","summary":"公司收购玉溪沃森少数股东股权事项的相关情况，公司已在巨潮资讯网披露的公告中进行说明，具体请以公司公告为准。本次收购完成后，公司持有玉溪沃森的股权比例进一步提升，有利于增强公司对子公司的管控和资源整合效率，提高玉溪沃森决策效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400016764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300142","BK0046","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663053850","title":"沃森生物：新型冠状病毒变异株mRNA疫苗正推进上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2663053850","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663053850?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:51","pubTimestamp":1788180697,"startTime":"0","endTime":"0","summary":"公司基于已构建的mRNA技术平台迭代开发的新型冠状病毒变异株mRNA疫苗正积极推进申请上市许可的药品注册相关工作；呼吸道合胞病毒mRNA疫苗、冻干带状疱疹病毒mRNA疫苗均已获得《药物临床试验批准通知书》，正在开展I期临床试验准备相关工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100034396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142","BK0070","BK0239","BK0077","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079198","title":"沃森生物（300142）披露2026年半年度报告，8月31日股价下跌4.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079198","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663079198?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:37","pubTimestamp":1788169029,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，沃森生物报收于13.59元，较前一交易日下跌4.83%，最新总市值为217.35亿元。该股当日开盘13.87元，最高14.06元，最低13.34元，成交额达20.36亿元，换手率为9.49%。公司于近日披露《2026年半年度报告》。公告显示，本报告期营业收入为834,215,184.81元，较上年同期下降27.72%；归属于上市公司股东的净利润为54,192,194.54元，同比增长25.56%；归属于上市公司股东的扣除非经常性损益的净利润为94,944,847.48元，同比增长233.81%；经营活动产生的现金流量净额为173,917,286.99元，同比增长49.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100024148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142","BK0070","BK0239","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663209130","title":"沃森生物：已建立mRNA疫苗研发到商业化生产的完整能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2663209130","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663209130?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:04","pubTimestamp":1788159856,"startTime":"0","endTime":"0","summary":"公司持续开展基于mRNA平台技术的疫苗开发，已经建立了从研发、中试到商业化生产的完整能力，并在相关产品的研发上取得了阶段性进展。关于公司mRNA疫苗的具体技术细节、研发进度及生产布局，请参阅公司在巨潮资讯网披露的定期报告及相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100014766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","300142","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663966012","title":"沃森生物(300142)6月30日股东户数13.1万户，较上期增加10.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663966012","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663966012?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:16","pubTimestamp":1787995001,"startTime":"0","endTime":"0","summary":"证券之星消息，近日沃森生物披露，截至2026年6月30日公司股东户数为13.1万户，较3月31日增加1.25万户，增幅为10.56%。在生物制品行业个股中，沃森生物股东户数高于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.54万户。从股价来看，2026年3月31日至2026年6月30日，沃森生物区间涨幅为5.86%，在此期间股东户数增加1.25万户，增幅为10.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300142","BK0070","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013339","title":"图解沃森生物中报：第二季度单季净利润同比下降239.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013339","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663013339?lang=zh_cn&edition=full","pubTime":"2026-08-29 03:24","pubTimestamp":1787945058,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物2026年中报显示，上半年度公司主营收入8.34亿元，同比下降27.72%；归母净利润5419.22万元，同比上升25.56%；扣非净利润9494.48万元，同比上升233.81%；其中2026年第二季度，公司单季度主营收入3.9亿元，同比下降43.58%；单季度归母净利润-5648.48万元，同比下降239.42%；单季度扣非净利润-1871.65万元，同比下降146.87%；负债率30.18%，投资收益-7.5万元，财务费用1272.43万元，毛利率68.79%。财报数据概要请见下图:本文数据来源于沃森生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900007366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270713","title":"沃森生物最新公告：定增申请获深交所受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270713","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662270713?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:29","pubTimestamp":1787833792,"startTime":"0","endTime":"0","summary":"沃森生物(300142.SZ)公告称，公司于2026年8月27日收到深交所通知，深交所对公司报送的2026年度向特定对象发行股票申请文件核对后决定予以受理。本次发行尚需通过深交所审核并获证监会同意注册后方可实施，最终能否获批存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700050410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142","BK0046","BK0070","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662702732","title":"沃森生物：2026年度向特定对象发行股票获深交所受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2662702732","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662702732?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:16","pubTimestamp":1787832965,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0070","BK0046","BK0239","300142","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796004","title":"8月26日沃森生物涨5.83%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796004","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662796004?lang=zh_cn&edition=full","pubTime":"2026-08-26 16:37","pubTimestamp":1787733429,"startTime":"0","endTime":"0","summary":"证券之星消息，8月26日沃森生物涨5.83%，收盘报15.26元，换手率19.07%，成交量300.82万手，成交额46.38亿元。重仓沃森生物的前十大公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600036845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK0077","300142","BK0046","BK0070","BK0239","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221713","title":"8月24日沃森生物跌7.45%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221713","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661221713?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:39","pubTimestamp":1787560783,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日沃森生物跌7.45%，收盘报14.9元，换手率20.79%，成交量327.96万手，成交额50.58亿元。重仓沃森生物的前十大公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400022090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","399441","161726","BK0046","BK0239","300142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661265769","title":"8月21日沃森生物涨6.48%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661265769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661265769?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:45","pubTimestamp":1787301939,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日沃森生物涨6.48%创60日新高，收盘报16.1元，换手率32.29%，成交量509.27万手，成交额81.79亿元。重仓沃森生物的前十大公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300142","BK0070","BK0239","161726","BK0077","399441","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660066402","title":"8月20日沃森生物创60日新高，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660066402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660066402?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:41","pubTimestamp":1787215318,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日沃森生物涨20.00%创60日新高，收盘报15.12元，换手率4.25%，成交量67.09万手，成交额10.14亿元。重仓沃森生物的前十大公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","300142","399441","BK0077","BK0239","BK0046","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660727484","title":"生物疫苗股全线大涨，康希诺等5股20CM涨停，默沙东莫德纳黑色素瘤疫苗临床试验传捷报","url":"https://stock-news.laohu8.com/highlight/detail?id=2660727484","media":"格隆汇","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660727484?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:47","pubTimestamp":1787190439,"startTime":"0","endTime":"0","summary":"8月20日，A股市场生物疫苗股全线大涨，其中，百克生物、康希诺、沃森生物、莱美药业、智飞生物20CM涨停，康华生物逼近20CM涨停，康泰生物涨超17%，华兰疫苗涨超10%，德展健康、双鹭药业、海普瑞、海欣股份、万泰生物10CM涨停，金迪克、博晖创新涨超7%，西藏药业、卫光生物、利德曼、冠昊生物、塞力医疗、赛升药业、申联生物、欧林生物涨超6%。消息面上，默沙东与莫德纳周三宣布，联合研发的黑色素瘤皮肤癌疫苗在首次晚期临床试验中取得积极初步结果。\n\n港股频道更多独家策划、专家专栏，免费查阅>>\n\n 责任编辑：栎树","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2026/08/cms_20260820094719181.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/08/cms_20260820094719181.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/08/20094758182842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1699723380.USD","LU2580892789.USD","VHT","LU2125909247.SGD","BK4007","LU1057294990.SGD","LU2461242641.AUD","300006","688276","IE00BSNM7G36.USD","LU1989772923.USD","LU0320765489.SGD","LU1917777945.USD","LU1328615791.USD","LU0861579265.USD","LU0942090050.USD","LU1974910355.USD","LU1291159041.SGD","LU1023059063.AUD","SG9999015341.SGD","LU1989771016.USD","LU1116320737.USD","LU1116320901.HKD","LU2112291526.USD","SG9999014567.USD","LU1093756168.USD","SG9999001440.SGD","LU0070302665.USD","LU2357627491.SGD","LU0124676726.USD","LU2580892862.HKD","SG9999015358.SGD","BK4533","JDOC","300122","LU1585245621.USD","LU1941712264.USD","LU0203345920.USD","301207","LU1934455863.HKD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU0965508806.USD","LU2360032135.SGD","LU0289739699.SGD","BK4559","WDNA","LU0238689110.USD","300142","GNOM","LU1923622614.USD","LU1037948541.HKD","LU2023250504.SGD","BK4551","IE0002141913.USD","IE00B2B36J28.USD","GDOC","LU1037948897.HKD","LU1093756325.SGD","SG9999014559.SGD","BK0077","LU0130102774.USD","LU0122379950.USD","LU2125909593.SGD","BK0239","BK4550","LU0689626769.HKD","BK4534","LU1066051225.USD","SG9999001176.SGD","BK4588","LU0266013472.USD","LU1064131003.USD","LU1066051498.USD","LU1929549753.HKD","LU0106261372.USD","LU0648001328.SGD","IE00BLSP4452.SGD","MRNY","LU0965509010.AUD","LU2491049909.HKD","SG9999013999.USD","LU0098860793.USD","IE00BJJMRZ35.SGD","BK4501","LU2361045086.USD","SG9999002232.USD","TRUH","IE00B1BXHZ80.USD","LU0985320562.USD","BK4548","HRTS","LU1035773651.USD","SG9999001176.USD","LU2106854487.HKD","BK0188","LU2089984988.USD","LU0208291251.USD","IDNA","LU1061106388.HKD","PAWZ","SG9999014575.USD","LU0868494708.USD","LU2324357040.USD","LU1064130708.USD","LU2125154778.USD","LU0477156953.USD","LU2023250843.SGD","FTXH","LGHT","IE000M9KFDE8.USD","LU0265550946.USD","LU1941712348.USD","LU2361044949.HKD","LU1066051811.HKD","BK4516","LU2125154935.USD","FHLC","LU0058720904.USD","SG9999014542.SGD","IHE","IXJ","BK0196","XLV","LU1983299246.USD","BK4568","LU1069347547.HKD","688185","BK0046","MRK","LU2361044865.SGD","LU1066053197.SGD","IE00BN8TJ469.HKD","RXL","MRNX","LU0203347892.USD","LU0859254822.USD","LU1571399168.USD","SGXZ57979304.SGD","PPH","LU2148510915.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","IE0009355771.USD","LU1934455277.USD","LU0130517989.USD","IE00BJT1NW94.SGD","LU0211331839.USD","06185","IE00BLSP4239.USD","LU2491050071.SGD","LU1430594728.SGD","LU0868494617.USD","BK4532","LU0265550359.USD","LU0006306889.USD","LU1989772840.SGD","LU0320765646.SGD","LU1934455194.USD","LU0965509283.SGD","MRNA","LU2433249047.HKD","LU1201861249.SGD","BK0070","LU0980610538.SGD","BK4139","LU1162221912.USD","LU2491050154.USD","LU0965509101.SGD","IYH","IE00BBT3K403.USD","SG9999002224.SGD","LU0432979614.USD","LU0234572021.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660472123","title":"四大指数集体高开！生物医药板块大爆发，康希诺、沃森生物一字20CM涨停，农业、煤炭板块下跌｜开盘播报","url":"https://stock-news.laohu8.com/highlight/detail?id=2660472123","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660472123?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:38","pubTimestamp":1787189887,"startTime":"0","endTime":"0","summary":"8月20日，A股主要指数集体高开，上证指数高开0.33%，深证成指高开1.03%，创业板指高开1.27%，科创综指高开1.35%。生物医药板块爆发，创新药、ADC、基因检测、CRO方向领涨，贵金属板块表现亮眼；农业、煤炭板块表现低迷。消息面上，昨夜美股纳斯达克生物科技指数大涨6.4%，创下六年来最大涨幅；Moderna飙升176%，市值增加440亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608203847305243.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608203847305243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159041","399441","BK0070","BK0077","161726","BK4585","688185","BK4588","XBI","BK4581","300142","BK0239","161032","BK0046"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790660098406,"stockEarnings":[{"period":"1week","weight":-0.0066},{"period":"1month","weight":-0.0476},{"period":"3month","weight":0.047},{"period":"6month","weight":0.0732},{"period":"1year","weight":0.2029},{"period":"ytd","weight":0.2624}],"compareEarnings":[{"period":"1week","weight":-0.032},{"period":"1month","weight":-0.0325},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0316},{"period":"1year","weight":-0.0012},{"period":"ytd","weight":-0.0366}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南沃森生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"130959人(较上一季度增加10.56%)","perCapita":"12048股","listingDate":"2010-11-12","address":"云南省昆明市五华区高新区科新路395号","registeredCapital":"159934万元","survey":" 云南沃森生物技术股份有限公司的主营业务是人用疫苗等生物技术药的研发、生产和销售。公司的主要产品是疫苗产品。","listedPrice":95},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沃森生物(300142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沃森生物(300142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沃森生物,300142,沃森生物股票,沃森生物股票老虎,沃森生物股票老虎国际,沃森生物行情,沃森生物股票行情,沃森生物股价,沃森生物股市,沃森生物股票价格,沃森生物股票交易,沃森生物股票购买,沃森生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沃森生物(300142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沃森生物(300142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}